A detailed history of Prudential Financial Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 14,475 shares of AQST stock, worth $69,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,475
Holding current value
$69,045
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.4 - $5.09 $34,740 - $73,677
14,475 New
14,475 $72,000
Q1 2024

May 14, 2024

SELL
$2.01 - $6.09 $9,647 - $29,232
-4,800 Reduced 19.2%
20,200 $86,000
Q3 2023

Nov 13, 2023

BUY
$1.5 - $2.24 $3,900 - $5,824
2,600 Added 11.61%
25,000 $38,000
Q2 2023

Aug 11, 2023

BUY
$1.06 - $2.49 $23,744 - $55,776
22,400 New
22,400 $36,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $254M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.